Life sciences investor New Rhein sells respiratory company Softhale to Sino Biopharm
New Rhein Healthcare Investors announced has agreed to sell its 60 per cent stake in Softhale NV to Sino Biopharmaceutical Limited for a USD110 million upfront payment plus a profit share. The total deal value could exceed USD200 million subject to Softhale’s business development. The sale of Softhale marks the